Overview
Transgene Biotek Ltd, founded in 1990, is a pioneering biotechnology company in India, focusing on research and development of vaccines, oncology products, and new drug delivery technologies.
The company has a robust product export portfolio, reaching markets in Africa, Russia, China, Malaysia, and the Philippines.
A significant development includes the planned setup of a manufacturing facility at Anrich Industrial Area with a Rs. 30 crore investment, supported by preferential offer funding from Batterymarch Financial Management USA and other financial institutions.
Transgene is advancing in novel delivery systems for proteins, peptides, and biologicals, with a particular emphasis on oral and nasal formulations.
The company targets novel therapies in oncology and auto-immune diseases, addressing vital areas of unmet medical need.
- Sector
Healthcare Services
- Industry
Healthcare Service Provider
- Market Cap
23 Cr
- Volatility
Moderate Risk
- P/E Ratio
-8.9
- Industry P/E
56.3
- PEG Ratio
—
- P/B Ratio
2.5
- 52W High
5.26
- 52W Low
1.83
Financial Ratios
Sales CAGR
- 1Y
- 13.04%
- 3Y
- 44.34%
- 5Y
- 135.81%
- 10Y
- 4.10%
Profit CAGR
- 1Y
- -3.03%
- 3Y
- —
- 5Y
- —
- 10Y
- —
ROE
- TTM
- -17.64%
- 3Y
- -22.86%
- 5Y
- -39.28%
- 10Y
- -22.08%
ROCE
- TTM
- -3.52%
- 3Y
- -1.72%
- 5Y
- -4.02%
- 10Y
- -5.55%
Peers
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
35.75 | 31 Cr | -32.80 | 0.00 | 0.00 | 35.31 | -0.76 | -3.69 | ||
15.44 | 31 Cr | 24.90 | 1.15 | 0.00 | 6.34 | 9.29 | 4.08 | ||
8.25 | 30 Cr | 8.90 | 0.27 | 0.00 | 1.30 | 1.99 | 1.64 | ||
2.22 | 23 Cr | -8.88 | 2.46 | 0.00 | -17.64 | -3.52 | -1.32 | ||
13.90 | 21 Cr | 9.79 | 0.31 | 0.00 | 3.32 | 6.57 | 2.69 | ||
3.23 | 17 Cr | -3.14 | 2.13 | 0.00 | -78.55 | -49.37 | -11.60 | ||
28.77 | 11 Cr | 43.59 | 1.08 | 0.00 | 0.99 | 1.37 | 0.76 | ||
| Median: 7 Co. | — | 13.90 | 23 Cr | 8.90 | 1.08 | 0.00 | 1.30 | 1.37 | 0.76 |
Price Chart Comparison
Documents
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
